Light-controlled ‘drug-free’ macromolecules for precise tumor therapy

Light-controlled “drug-free” macromolecules for precise tumor therapy
Credit: Zhejiang University

Drug-free macromolecular therapies can induce cell apoptosis by clustering non-internalizing cell-surface receptors. These show enormous promise in tumor treatment, particularly in terms of non-specific toxicities when compared with low-molecular-weight drugs. However, most reported drug-free macromolecular therapies involve a ‘two-step’ administration manner and there is a paucity of in vivo research.

On December 23, 2021, the research team led by Prof. Du Yongzhong at the College of Pharmaceutical Sciences, Zhejiang University, published an article entitled “Spatiotemporally light controlled ‘drug-free’ macromolecules via upconversion-nanoparticle for precise tumor therapy” in the journal Nano Today.

Du’s team synthesized light-controlled ‘drug-free’ macromolecules consisting of up-conversion nanoparticles, aptamers, water-soluble polymers, and cinnamate (CA) groups. These were first highly accumulated at tumor sites mediated by aptamers and precisely localized to receptors on the surface of tumor cell membranes. The up-conversion nanoparticles converted near- into ultra-violet light and induced the cross-linking of CA groups, thus resulting in the clustering of CD20 receptors and . No apoptosis occurred in light-free sites. Therefore, tumors could be precisely treated in a safe and efficient manner. This strategy was confirmed by in situ and intravenous administration in tumor model animals.

“This near-infrared up-conversion controlled, in-situ synthesized drug-free macromolecular therapeutics expands the repertoire of macromolecular drugs and opens a new avenue for tumor therapy,” said Du.



More information: Jun Wang et al, Spatiotemporally light controlled “drug-free” macromolecules via upconversion-nanoparticle for precise tumor therapy, Nano Today (2021). DOI: 10.1016/j.nantod.2021.101360

Provided byZhejiang University

Citation: Light-controlled ‘drug-free’ macromolecules for precise tumor therapy (2022, January 7) retrieved 22 January 2022 from https://phys.org/news/2022-01-light-controlled-drug-free-macromolecules-precise-tumor.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
'Deadly serious': Labor mulls budget measures to address women's economic inequality thumbnail

‘Deadly serious’: Labor mulls budget measures to address women’s economic inequality

Key PointsThe government is considering several recommendations from the Women's Economic Equality Taskforce to support women.The task force called for a boost to rent assistance to provide immediate relief to women experiencing housing stress.Finance Minister Katy Gallagher said the government was "deadly serious" about women's economic equality.More financial support for women in housing stress remains
Read More
‘Most hated man in video games’: The scandalous reign of Call of Duty billionaire thumbnail

‘Most hated man in video games’: The scandalous reign of Call of Duty billionaire

By James Titcomb and Matt OliverJanuary 20, 2022 — 11.00amBobby Kotick was bursting with optimism as he told staff about his video game company’s $US69 billion ($96 billion) sale to Microsoft. The 58-year-old Activision Blizzard boss painted the deal as a “partnership to define the future” of the industry that creates “endless possibilities for us”.The…
Read More
Space SPACs look to rebound in 2022 thumbnail

Space SPACs look to rebound in 2022

by Jeff Foust — January 3, 2022 Planet executives were cheering the company’s debut on the New York Stock Exchange Dec. 8, but the company's share price had dropped by more than 40% as of Dec. 31. Credit: NYSE screenshot WASHINGTON — Space companies used mergers with special purpose acquisition corporations, or SPACs, to grow…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share